APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ceftriaxone

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ceftriaxone Market Analysis and Forecast 2026-2032

30 December 2025198 pages

Choose your research edition.

Industry ResearchCeftriaxone Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Ceftriaxone Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Ceftriaxone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ceftriaxone Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Ceftriaxone Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Ceftriaxone market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ceftriaxone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ceftriaxone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ceftriaxone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ceftriaxone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ceftriaxone include Qilu Pharmaceutical, Novartis, Baxter International, Orchid Pharma, Nectar Lifesciences, Lupin Pharmaceuticals, Hikma Pharmaceuticals, Aurobindo Pharma and ACS DOBFAR, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ceftriaxone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ceftriaxone, also provides the sales of main regions and countries. Of the upcoming market potential for Ceftriaxone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ceftriaxone sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ceftriaxone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ceftriaxone sales, projected growth trends, production technology, application and end-user industry.

Ceftriaxone Segment by Company

Qilu Pharmaceutical

Novartis

Baxter International

Orchid Pharma

Nectar Lifesciences

Lupin Pharmaceuticals

Hikma Pharmaceuticals

Aurobindo Pharma

ACS DOBFAR

Ceftriaxone Segment by Type

Intravenous Injection

Intramuscular Injection

Ceftriaxone Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Ceftriaxone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceftriaxone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ceftriaxone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceftriaxone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ceftriaxone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ceftriaxone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ceftriaxone sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ceftriaxone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Intravenous Injection Major Manufacturers Table 3. Intramuscular Injection Major Manufacturers Table 4. Global Ceftriaxone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Retail Pharmacies Major Manufacturers Table 6. Online Pharmacies Major Manufacturers Table 7. Hospital Pharmacies Major Manufacturers Table 8. Ceftriaxone Industry Trends Table 9. Ceftriaxone Industry Drivers Table 10. Ceftriaxone Industry Opportunities and Challenges Table 11. Ceftriaxone Industry Restraints Table 12. Global Ceftriaxone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Ceftriaxone Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Ceftriaxone Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Ceftriaxone Revenue Market Share by Region (2021-2026) Table 16. Global Ceftriaxone Revenue Market Share by Region (2027-2032) Table 17. Global Ceftriaxone Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Ceftriaxone Sales by Region (2021-2026) & (K Units) Table 19. Global Ceftriaxone Sales by Region (2027-2032) & (K Units) Table 20. Global Ceftriaxone Sales Market Share by Region (2021-2026) Table 21. Global Ceftriaxone Sales Market Share by Region (2027-2032) Table 22. Global Ceftriaxone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Ceftriaxone Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Ceftriaxone Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Ceftriaxone Sales Market Share by Manufacturers (2021-2026) Table 26. Global Ceftriaxone Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Ceftriaxone Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Ceftriaxone Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Ceftriaxone Manufacturers, Product Type & Application Table 30. Global Ceftriaxone Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Ceftriaxone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Ceftriaxone Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Ceftriaxone Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Ceftriaxone Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Ceftriaxone Revenue Market Share by Type (2021-2026) Table 37. Global Ceftriaxone Revenue Market Share by Type (2027-2032) Table 38. Global Ceftriaxone Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Ceftriaxone Sales by Type (2021-2026) & (K Units) Table 40. Global Ceftriaxone Sales by Type (2027-2032) & (K Units) Table 41. Global Ceftriaxone Sales Market Share by Type (2021-2026) Table 42. Global Ceftriaxone Sales Market Share by Type (2027-2032) Table 43. Global Ceftriaxone Price by Type (2021-2026) & (US$/Unit) Table 44. Global Ceftriaxone Price by Type (2027-2032) & (US$/Unit) Table 45. Global Ceftriaxone Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Ceftriaxone Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Ceftriaxone Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Ceftriaxone Revenue Market Share by Application (2021-2026) Table 49. Global Ceftriaxone Revenue Market Share by Application (2027-2032) Table 50. Global Ceftriaxone Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Ceftriaxone Sales by Application (2021-2026) & (K Units) Table 52. Global Ceftriaxone Sales by Application (2027-2032) & (K Units) Table 53. Global Ceftriaxone Sales Market Share by Application (2021-2026) Table 54. Global Ceftriaxone Sales Market Share by Application (2027-2032) Table 55. Global Ceftriaxone Price by Application (2021-2026) & (US$/Unit) Table 56. Global Ceftriaxone Price by Application (2027-2032) & (US$/Unit) Table 57. Qilu Pharmaceutical Company Information Table 58. Qilu Pharmaceutical Business Overview Table 59. Qilu Pharmaceutical Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Qilu Pharmaceutical Ceftriaxone Product Portfolio Table 61. Qilu Pharmaceutical Recent Development Table 62. Novartis Company Information Table 63. Novartis Business Overview Table 64. Novartis Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Novartis Ceftriaxone Product Portfolio Table 66. Novartis Recent Development Table 67. Baxter International Company Information Table 68. Baxter International Business Overview Table 69. Baxter International Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Baxter International Ceftriaxone Product Portfolio Table 71. Baxter International Recent Development Table 72. Orchid Pharma Company Information Table 73. Orchid Pharma Business Overview Table 74. Orchid Pharma Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Orchid Pharma Ceftriaxone Product Portfolio Table 76. Orchid Pharma Recent Development Table 77. Nectar Lifesciences Company Information Table 78. Nectar Lifesciences Business Overview Table 79. Nectar Lifesciences Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Nectar Lifesciences Ceftriaxone Product Portfolio Table 81. Nectar Lifesciences Recent Development Table 82. Lupin Pharmaceuticals Company Information Table 83. Lupin Pharmaceuticals Business Overview Table 84. Lupin Pharmaceuticals Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Lupin Pharmaceuticals Ceftriaxone Product Portfolio Table 86. Lupin Pharmaceuticals Recent Development Table 87. Hikma Pharmaceuticals Company Information Table 88. Hikma Pharmaceuticals Business Overview Table 89. Hikma Pharmaceuticals Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Hikma Pharmaceuticals Ceftriaxone Product Portfolio Table 91. Hikma Pharmaceuticals Recent Development Table 92. Aurobindo Pharma Company Information Table 93. Aurobindo Pharma Business Overview Table 94. Aurobindo Pharma Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Aurobindo Pharma Ceftriaxone Product Portfolio Table 96. Aurobindo Pharma Recent Development Table 97. ACS DOBFAR Company Information Table 98. ACS DOBFAR Business Overview Table 99. ACS DOBFAR Ceftriaxone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. ACS DOBFAR Ceftriaxone Product Portfolio Table 101. ACS DOBFAR Recent Development Table 102. North America Ceftriaxone Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Ceftriaxone Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Ceftriaxone Sales by Type (2021-2026) & (K Units) Table 105. North America Ceftriaxone Sales by Type (2027-2032) & (K Units) Table 106. North America Ceftriaxone Sales Price by Type (2021-2026) & (US$/Unit) Table 107. North America Ceftriaxone Sales Price by Type (2027-2032) & (US$/Unit) Table 108. North America Ceftriaxone Revenue by Application (2021-2026) & (US$ Million) Table 109. North America Ceftriaxone Revenue by Application (2027-2032) & (US$ Million) Table 110. North America Ceftriaxone Sales by Application (2021-2026) & (K Units) Table 111. North America Ceftriaxone Sales by Application (2027-2032) & (K Units) Table 112. North America Ceftriaxone Sales Price by Application (2021-2026) & (US$/Unit) Table 113. North America Ceftriaxone Sales Price by Application (2027-2032) & (US$/Unit) Table 114. North America Ceftriaxone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Ceftriaxone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. North America Ceftriaxone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. North America Ceftriaxone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 118. North America Ceftriaxone Sales by Country (2021-2026) & (K Units) Table 119. North America Ceftriaxone Sales by Country (2027-2032) & (K Units) Table 120. North America Ceftriaxone Sales Price by Country (2021-2026) & (US$/Unit) Table 121. North America Ceftriaxone Sales Price by Country (2027-2032) & (US$/Unit) Table 122. United States Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 123. Canada Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 124. Europe Ceftriaxone Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Ceftriaxone Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Ceftriaxone Sales by Type (2021-2026) & (K Units) Table 127. Europe Ceftriaxone Sales by Type (2027-2032) & (K Units) Table 128. Europe Ceftriaxone Sales Price by Type (2021-2026) & (US$/Unit) Table 129. Europe Ceftriaxone Sales Price by Type (2027-2032) & (US$/Unit) Table 130. Europe Ceftriaxone Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Ceftriaxone Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Ceftriaxone Sales by Application (2021-2026) & (K Units) Table 133. Europe Ceftriaxone Sales by Application (2027-2032) & (K Units) Table 134. Europe Ceftriaxone Sales Price by Application (2021-2026) & (US$/Unit) Table 135. Europe Ceftriaxone Sales Price by Application (2027-2032) & (US$/Unit) Table 136. Europe Ceftriaxone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Ceftriaxone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Ceftriaxone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Ceftriaxone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 140. Europe Ceftriaxone Sales by Country (2021-2026) & (K Units) Table 141. Europe Ceftriaxone Sales by Country (2027-2032) & (K Units) Table 142. Europe Ceftriaxone Sales Price by Country (2021-2026) & (US$/Unit) Table 143. Europe Ceftriaxone Sales Price by Country (2027-2032) & (US$/Unit) Table 144. Germany Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 145. France Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 146. U.K. Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 147. Italy Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 148. Netherlands Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 149. China Ceftriaxone Revenue by Type (2021-2026) & (US$ Million) Table 150. China Ceftriaxone Revenue by Type (2027-2032) & (US$ Million) Table 151. China Ceftriaxone Sales by Type (2021-2026) & (K Units) Table 152. China Ceftriaxone Sales by Type (2027-2032) & (K Units) Table 153. China Ceftriaxone Sales Price by Type (2021-2026) & (US$/Unit) Table 154. China Ceftriaxone Sales Price by Type (2027-2032) & (US$/Unit) Table 155. China Ceftriaxone Revenue by Application (2021-2026) & (US$ Million) Table 156. China Ceftriaxone Revenue by Application (2027-2032) & (US$ Million) Table 157. China Ceftriaxone Sales by Application (2021-2026) & (K Units) Table 158. China Ceftriaxone Sales by Application (2027-2032) & (K Units) Table 159. China Ceftriaxone Sales Price by Application (2021-2026) & (US$/Unit) Table 160. China Ceftriaxone Sales Price by Application (2027-2032) & (US$/Unit) Table 161. Asia Ceftriaxone Revenue by Type (2021-2026) & (US$ Million) Table 162. Asia Ceftriaxone Revenue by Type (2027-2032) & (US$ Million) Table 163. Asia Ceftriaxone Sales by Type (2021-2026) & (K Units) Table 164. Asia Ceftriaxone Sales by Type (2027-2032) & (K Units) Table 165. Asia Ceftriaxone Sales Price by Type (2021-2026) & (US$/Unit) Table 166. Asia Ceftriaxone Sales Price by Type (2027-2032) & (US$/Unit) Table 167. Asia Ceftriaxone Revenue by Application (2021-2026) & (US$ Million) Table 168. Asia Ceftriaxone Revenue by Application (2027-2032) & (US$ Million) Table 169. Asia Ceftriaxone Sales by Application (2021-2026) & (K Units) Table 170. Asia Ceftriaxone Sales by Application (2027-2032) & (K Units) Table 171. Asia Ceftriaxone Sales Price by Application (2021-2026) & (US$/Unit) Table 172. Asia Ceftriaxone Sales Price by Application (2027-2032) & (US$/Unit) Table 173. Asia Ceftriaxone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Asia Ceftriaxone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Asia Ceftriaxone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Asia Ceftriaxone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 177. Asia Ceftriaxone Sales by Country (2021-2026) & (K Units) Table 178. Asia Ceftriaxone Sales by Country (2027-2032) & (K Units) Table 179. Asia Ceftriaxone Sales Price by Country (2021-2026) & (US$/Unit) Table 180. Asia Ceftriaxone Sales Price by Country (2027-2032) & (US$/Unit) Table 181. Japan Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 182. South Korea Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 183. India Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 184. Australia Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 185. China Taiwan Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 186. Southeast Asia Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 187. SAMEA Ceftriaxone Revenue by Type (2021-2026) & (US$ Million) Table 188. SAMEA Ceftriaxone Revenue by Type (2027-2032) & (US$ Million) Table 189. SAMEA Ceftriaxone Sales by Type (2021-2026) & (K Units) Table 190. SAMEA Ceftriaxone Sales by Type (2027-2032) & (K Units) Table 191. SAMEA Ceftriaxone Sales Price by Type (2021-2026) & (US$/Unit) Table 192. SAMEA Ceftriaxone Sales Price by Type (2027-2032) & (US$/Unit) Table 193. SAMEA Ceftriaxone Revenue by Application (2021-2026) & (US$ Million) Table 194. SAMEA Ceftriaxone Revenue by Application (2027-2032) & (US$ Million) Table 195. SAMEA Ceftriaxone Sales by Application (2021-2026) & (K Units) Table 196. SAMEA Ceftriaxone Sales by Application (2027-2032) & (K Units) Table 197. SAMEA Ceftriaxone Sales Price by Application (2021-2026) & (US$/Unit) Table 198. SAMEA Ceftriaxone Sales Price by Application (2027-2032) & (US$/Unit) Table 199. SAMEA Ceftriaxone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. SAMEA Ceftriaxone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. SAMEA Ceftriaxone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. SAMEA Ceftriaxone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 203. SAMEA Ceftriaxone Sales by Country (2021-2026) & (K Units) Table 204. SAMEA Ceftriaxone Sales by Country (2027-2032) & (K Units) Table 205. SAMEA Ceftriaxone Sales Price by Country (2021-2026) & (US$/Unit) Table 206. SAMEA Ceftriaxone Sales Price by Country (2027-2032) & (US$/Unit) Table 207. Brazil Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 208. Argentina Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 209. Chile Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 210. Colombia Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 211. Peru Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 212. Saudi Arabia Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 213. Israel Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 214. UAE Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 215. Turkey Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 216. Iran Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 217. Egypt Ceftriaxone Revenue (2021-2032) & (US$ Million) Table 218. Key Raw Materials Table 219. Raw Materials Key Suppliers Table 220. Ceftriaxone Distributors List Table 221. Ceftriaxone Customers List Table 222. Research Programs/Design for This Report Table 223. Authors List of This Report Table 224. Secondary Sources Table 225. Primary Sources List of Figures Figure 1. Ceftriaxone Image Figure 2. Global Ceftriaxone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ceftriaxone Market Size Share 2021 VS 2025 VS 2032 Figure 4. Intravenous Injection Image Figure 5. Intramuscular Injection Image Figure 6. Global Ceftriaxone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ceftriaxone Market Size Share 2021 VS 2025 VS 2032 Figure 8. Retail Pharmacies Image Figure 9. Online Pharmacies Image Figure 10. Hospital Pharmacies Image Figure 11. Global Ceftriaxone Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Ceftriaxone Revenue (2021-2032) & (US$ Million) Figure 13. Global Ceftriaxone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Ceftriaxone Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Ceftriaxone Revenue Market Share by Region (2021-2032) Figure 16. Global Ceftriaxone Sales (2021-2032) & (K Units) Figure 17. Global Ceftriaxone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Ceftriaxone Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Ceftriaxone Sales YoY (2021-2032) & (K Units) Figure 20. Europe Ceftriaxone Sales YoY (2021-2032) & (K Units) Figure 21. China Ceftriaxone Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Ceftriaxone Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Ceftriaxone Sales YoY (2021-2032) & (K Units) Figure 24. Global Ceftriaxone Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Ceftriaxone Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Ceftriaxone Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Ceftriaxone Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Ceftriaxone Revenue Market Share by Type (2021-2032) Figure 30. Global Ceftriaxone Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Ceftriaxone Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Ceftriaxone Sales Market Share by Type (2021-2032) Figure 33. Global Ceftriaxone Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Ceftriaxone Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Ceftriaxone Revenue Market Share by Application (2021-2032) Figure 36. Global Ceftriaxone Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Ceftriaxone Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Ceftriaxone Sales Market Share by Application (2021-2032) Figure 39. North America Ceftriaxone Revenue Share by Type (2021-2032) Figure 40. North America Ceftriaxone Sales Share by Type (2021-2032) Figure 41. North America Ceftriaxone Revenue Share by Application (2021-2032) Figure 42. North America Ceftriaxone Sales Share by Application (2021-2032) Figure 43. North America Ceftriaxone Revenue Share by Country (2021-2032) Figure 44. North America Ceftriaxone Sales Share by Country (2021-2032) Figure 45. Europe Ceftriaxone Revenue Share by Type (2021-2032) Figure 46. Europe Ceftriaxone Sales Share by Type (2021-2032) Figure 47. Europe Ceftriaxone Revenue Share by Application (2021-2032) Figure 48. Europe Ceftriaxone Sales Share by Application (2021-2032) Figure 49. Europe Ceftriaxone Revenue Share by Country (2021-2032) Figure 50. Europe Ceftriaxone Sales Share by Country (2021-2032) Figure 51. China Ceftriaxone Revenue Share by Type (2021-2032) Figure 52. China Ceftriaxone Sales Share by Type (2021-2032) Figure 53. China Ceftriaxone Revenue Share by Application (2021-2032) Figure 54. China Ceftriaxone Sales Share by Application (2021-2032) Figure 55. Asia Ceftriaxone Revenue Share by Type (2021-2032) Figure 56. Asia Ceftriaxone Sales Share by Type (2021-2032) Figure 57. Asia Ceftriaxone Revenue Share by Application (2021-2032) Figure 58. Asia Ceftriaxone Sales Share by Application (2021-2032) Figure 59. Asia Ceftriaxone Revenue Share by Country (2021-2032) Figure 60. Asia Ceftriaxone Sales Share by Country (2021-2032) Figure 61. SAMEA Ceftriaxone Revenue Share by Type (2021-2032) Figure 62. SAMEA Ceftriaxone Sales Share by Type (2021-2032) Figure 63. SAMEA Ceftriaxone Revenue Share by Application (2021-2032) Figure 64. SAMEA Ceftriaxone Sales Share by Application (2021-2032) Figure 65. SAMEA Ceftriaxone Revenue Share by Country (2021-2032) Figure 66. SAMEA Ceftriaxone Sales Share by Country (2021-2032) Figure 67. Ceftriaxone Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Ceftriaxone Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Intravenous Injection
  • Intramuscular Injection
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Qilu Pharmaceutical
  • Novartis
  • Baxter International
  • Orchid Pharma
  • Nectar Lifesciences
  • Lupin Pharmaceuticals
  • Hikma Pharmaceuticals
  • Aurobindo Pharma
  • ACS DOBFAR

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ceftriaxone Market by Type
  3. 1.2.1 Global Ceftriaxone Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Intravenous Injection
  5. 1.2.3 Intramuscular Injection
  6. 1.3 Ceftriaxone Market by Application
  7. 1.3.1 Global Ceftriaxone Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Retail Pharmacies
  9. 1.3.3 Online Pharmacies
  10. 1.3.4 Hospital Pharmacies
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Ceftriaxone Market Dynamics
  1. 2.1 Ceftriaxone Industry Trends
  2. 2.2 Ceftriaxone Industry Drivers
  3. 2.3 Ceftriaxone Industry Opportunities and Challenges
  4. 2.4 Ceftriaxone Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ceftriaxone Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ceftriaxone Revenue by Region
  3. 3.2.1 Global Ceftriaxone Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ceftriaxone Revenue by Region (2021-2026)
  5. 3.2.3 Global Ceftriaxone Revenue by Region (2027-2032)
  6. 3.2.4 Global Ceftriaxone Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ceftriaxone Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ceftriaxone Sales by Region
  9. 3.4.1 Global Ceftriaxone Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ceftriaxone Sales by Region (2021-2026)
  11. 3.4.3 Global Ceftriaxone Sales by Region (2027-2032)
  12. 3.4.4 Global Ceftriaxone Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ceftriaxone Revenue by Manufacturers
  2. 4.1.1 Global Ceftriaxone Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ceftriaxone Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ceftriaxone Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ceftriaxone Sales by Manufacturers
  6. 4.2.1 Global Ceftriaxone Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ceftriaxone Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ceftriaxone Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ceftriaxone Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ceftriaxone Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ceftriaxone Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ceftriaxone Manufacturers, Product Type & Application
  13. 4.7 Global Ceftriaxone Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ceftriaxone Market CR5 and HHI
  16. 4.8.2 2025 Ceftriaxone Tier 1, Tier 2, and Tier 3
5 Ceftriaxone Market by Type
  1. 5.1 Global Ceftriaxone Revenue by Type
  2. 5.1.1 Global Ceftriaxone Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ceftriaxone Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ceftriaxone Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ceftriaxone Sales by Type
  6. 5.2.1 Global Ceftriaxone Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ceftriaxone Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Ceftriaxone Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ceftriaxone Price by Type
6 Ceftriaxone Market by Application
  1. 6.1 Global Ceftriaxone Revenue by Application
  2. 6.1.1 Global Ceftriaxone Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ceftriaxone Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ceftriaxone Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ceftriaxone Sales by Application
  6. 6.2.1 Global Ceftriaxone Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ceftriaxone Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Ceftriaxone Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ceftriaxone Price by Application
7 Company Profiles
  1. 7.1 Qilu Pharmaceutical
  2. 7.1.1 Qilu Pharmaceutical Company Information
  3. 7.1.2 Qilu Pharmaceutical Business Overview
  4. 7.1.3 Qilu Pharmaceutical Ceftriaxone Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Qilu Pharmaceutical Ceftriaxone Product Portfolio
  6. 7.1.5 Qilu Pharmaceutical Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Ceftriaxone Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Ceftriaxone Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Baxter International
  14. 7.3.1 Baxter International Company Information
  15. 7.3.2 Baxter International Business Overview
  16. 7.3.3 Baxter International Ceftriaxone Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Baxter International Ceftriaxone Product Portfolio
  18. 7.3.5 Baxter International Recent Developments
  19. 7.4 Orchid Pharma
  20. 7.4.1 Orchid Pharma Company Information
  21. 7.4.2 Orchid Pharma Business Overview
  22. 7.4.3 Orchid Pharma Ceftriaxone Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Orchid Pharma Ceftriaxone Product Portfolio
  24. 7.4.5 Orchid Pharma Recent Developments
  25. 7.5 Nectar Lifesciences
  26. 7.5.1 Nectar Lifesciences Company Information
  27. 7.5.2 Nectar Lifesciences Business Overview
  28. 7.5.3 Nectar Lifesciences Ceftriaxone Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Nectar Lifesciences Ceftriaxone Product Portfolio
  30. 7.5.5 Nectar Lifesciences Recent Developments
  31. 7.6 Lupin Pharmaceuticals
  32. 7.6.1 Lupin Pharmaceuticals Company Information
  33. 7.6.2 Lupin Pharmaceuticals Business Overview
  34. 7.6.3 Lupin Pharmaceuticals Ceftriaxone Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lupin Pharmaceuticals Ceftriaxone Product Portfolio
  36. 7.6.5 Lupin Pharmaceuticals Recent Developments
  37. 7.7 Hikma Pharmaceuticals
  38. 7.7.1 Hikma Pharmaceuticals Company Information
  39. 7.7.2 Hikma Pharmaceuticals Business Overview
  40. 7.7.3 Hikma Pharmaceuticals Ceftriaxone Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Hikma Pharmaceuticals Ceftriaxone Product Portfolio
  42. 7.7.5 Hikma Pharmaceuticals Recent Developments
  43. 7.8 Aurobindo Pharma
  44. 7.8.1 Aurobindo Pharma Company Information
  45. 7.8.2 Aurobindo Pharma Business Overview
  46. 7.8.3 Aurobindo Pharma Ceftriaxone Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Aurobindo Pharma Ceftriaxone Product Portfolio
  48. 7.8.5 Aurobindo Pharma Recent Developments
  49. 7.9 ACS DOBFAR
  50. 7.9.1 ACS DOBFAR Company Information
  51. 7.9.2 ACS DOBFAR Business Overview
  52. 7.9.3 ACS DOBFAR Ceftriaxone Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 ACS DOBFAR Ceftriaxone Product Portfolio
  54. 7.9.5 ACS DOBFAR Recent Developments
8 North America
  1. 8.1 North America Ceftriaxone Market Size by Type
  2. 8.1.1 North America Ceftriaxone Revenue by Type (2021-2032)
  3. 8.1.2 North America Ceftriaxone Sales by Type (2021-2032)
  4. 8.1.3 North America Ceftriaxone Price by Type (2021-2032)
  5. 8.2 North America Ceftriaxone Market Size by Application
  6. 8.2.1 North America Ceftriaxone Revenue by Application (2021-2032)
  7. 8.2.2 North America Ceftriaxone Sales by Application (2021-2032)
  8. 8.2.3 North America Ceftriaxone Price by Application (2021-2032)
  9. 8.3 North America Ceftriaxone Market Size by Country
  10. 8.3.1 North America Ceftriaxone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ceftriaxone Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ceftriaxone Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Ceftriaxone Market Size by Type
  2. 9.1.1 Europe Ceftriaxone Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ceftriaxone Sales by Type (2021-2032)
  4. 9.1.3 Europe Ceftriaxone Price by Type (2021-2032)
  5. 9.2 Europe Ceftriaxone Market Size by Application
  6. 9.2.1 Europe Ceftriaxone Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ceftriaxone Sales by Application (2021-2032)
  8. 9.2.3 Europe Ceftriaxone Price by Application (2021-2032)
  9. 9.3 Europe Ceftriaxone Market Size by Country
  10. 9.3.1 Europe Ceftriaxone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ceftriaxone Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ceftriaxone Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Ceftriaxone Market Size by Type
  2. 10.1.1 China Ceftriaxone Revenue by Type (2021-2032)
  3. 10.1.2 China Ceftriaxone Sales by Type (2021-2032)
  4. 10.1.3 China Ceftriaxone Price by Type (2021-2032)
  5. 10.2 China Ceftriaxone Market Size by Application
  6. 10.2.1 China Ceftriaxone Revenue by Application (2021-2032)
  7. 10.2.2 China Ceftriaxone Sales by Application (2021-2032)
  8. 10.2.3 China Ceftriaxone Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ceftriaxone Market Size by Type
  2. 11.1.1 Asia Ceftriaxone Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ceftriaxone Sales by Type (2021-2032)
  4. 11.1.3 Asia Ceftriaxone Price by Type (2021-2032)
  5. 11.2 Asia Ceftriaxone Market Size by Application
  6. 11.2.1 Asia Ceftriaxone Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ceftriaxone Sales by Application (2021-2032)
  8. 11.2.3 Asia Ceftriaxone Price by Application (2021-2032)
  9. 11.3 Asia Ceftriaxone Market Size by Country
  10. 11.3.1 Asia Ceftriaxone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ceftriaxone Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ceftriaxone Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ceftriaxone Market Size by Type
  2. 12.1.1 SAMEA Ceftriaxone Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ceftriaxone Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ceftriaxone Price by Type (2021-2032)
  5. 12.2 SAMEA Ceftriaxone Market Size by Application
  6. 12.2.1 SAMEA Ceftriaxone Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ceftriaxone Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ceftriaxone Price by Application (2021-2032)
  9. 12.3 SAMEA Ceftriaxone Market Size by Country
  10. 12.3.1 SAMEA Ceftriaxone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ceftriaxone Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ceftriaxone Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ceftriaxone Value Chain Analysis
  2. 13.1.1 Ceftriaxone Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ceftriaxone Production Mode & Process
  6. 13.2 Ceftriaxone Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ceftriaxone Distributors
  9. 13.2.3 Ceftriaxone Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst